MCID: SRT003
MIFTS: 51

Sertoli-Leydig Cell Tumor malady

Cancer diseases category

Summaries for Sertoli-Leydig Cell Tumor

About this section
Sources:
42NIH Rare Diseases, 63Wikipedia, 32MalaCards
See all sources

Fully expand this MalaCard

Export this MalaCard
NIH Rare Diseases:42 Sertoli-leydig cell tumors are a cancer that starts in the female ovaries. the cancer cells produce and release a male sex hormone which may cause the development of male physical characteristics (virilization), including facial hair and a deep voice. this type of tumor is sometimes called arrhenoblastoma of the ovary or a stromal tumor. sertoli-leydig cell tumors are rare tumors which account for less than 0.5% of all ovarian tumors. while they can be found in women of all age groups, they are most common in young women. treatment involves surgery and chemotherapy or radiation if the cancer has spread. because sertoli-leydig cell tumors have a low chance of spreading, if the tumor is found early, chances for survival are good. last updated: 3/25/2010

MalaCards: Sertoli-Leydig Cell Tumor, also known as sertoli-leydig cell tumor of the ovary, is related to sertoli cell tumor and leydig cell tumor. An important gene associated with Sertoli-Leydig Cell Tumor is DICER1 (dicer 1, ribonuclease type III), and among its related pathways are Mineralocorticoid biosynthesis and Androgen biosynthesis. The compounds dmrt and estrogen have been mentioned in the context of this disorder. Affiliated tissues include ovary, testis and skeletal muscle, and related mouse phenotypes are endocrine/exocrine gland and reproductive system.

Wikipedia:63 Sertoli-Leydig cell tumour is a group of tumours composed of variable proportions of Sertoli cells,... more...

Aliases & Classifications for Sertoli-Leydig Cell Tumor

About this section
Sources:
8Disease Ontology, 10DISEASES, 44Novoseek, 60UMLS, 42NIH Rare Diseases, 56SNOMED-CT, 34MeSH
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Cancer diseases


Aliases & Descriptions:

sertoli-leydig cell tumor 8 10 44 60
sertoli-leydig cell tumor of the ovary 42
sertoli-leydig cell tumors 42
arrhenoblastoma of ovary 42
androblastoma of ovary 42
arrhenoblastoma 42


External Ids:

Disease Ontology8 DOID:2997
SNOMED-CT56 34110004
MeSH34 D018310

Related Diseases for Sertoli-Leydig Cell Tumor

About this section
Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases in the Sertoli-Leydig Cell Tumor family:

Malignant Sertoli-Leydig Cell Tumor

Diseases related to Sertoli-Leydig Cell Tumor via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 176)
idRelated DiseaseScoreTop Affiliating Genes
1sertoli cell tumor31.9CALB2, SYP, MUC1, INHA, PGR, ENO2
2leydig cell tumor31.9INHA, HSD3B1, HSD3BP4, CALB2, NR5A1, CYP17A1
3androgen insensitivity syndrome30.9SRY
4cystadenoma30.8INHA, KRT7, CEACAM3
5sarcoma30.7CALB2, WT1, MLANA, MYOG, MUC1, ENO2
6amenorrhea30.6SRY
7rhabdomyosarcoma30.6CALB2, WT1, MYOG, INHA, ENO2
8adenoma30.6HSD3BP4, CALB2, SYP, NR5A1, MUC1, CYP17A1
9adenocarcinoma30.6CALB2, WT1, AFP, SYP, CEACAM3, ENO2
10hyperandrogenism30.4HSD3B1, HSD3BP4, CYP17A1, INSL3
11adrenal adenoma30.4HSD3BP4, CALB2, MLANA, SYP, NR5A1, CYP17A1
12cystadenocarcinoma29.9CEACAM3, MUC1
13mucinous cystadenocarcinoma29.9MUC1, KRT7, CEACAM3
14malignant sertoli-leydig cell tumor10.6
15goiter, multinodular 1, with or without sertoli-leydig cell tumors10.5
16ovarian malignant sertoli-leydig cell tumor10.5
17multinodular goiter10.4
18malignant sertoli cell tumor10.4
19cervicitis10.4
20goiter10.4
21malignant leydig cell tumor10.4
22ovarian cystadenoma10.4
23ovarian disease10.4
24rete testis adenocarcinoma10.3
25mucinous adenocarcinoma10.3
26breast adenoma10.3
27breast disease10.3
28cystic teratoma10.3
29dysgerminoma of ovary10.3
30mature teratoma10.3
31ovary adenocarcinoma10.3
32vaginitis10.3
33image syndrome10.3
34cystic nephroma10.0DICER1
35hepatitis10.0AFP
36premature ovarian failure10.0INHA
37adenosarcoma10.0PGR
38liposarcoma10.0CALB2
39malignant pleural mesothelioma10.0CALB2
40ductal carcinoma in situ10.0PGR
41placental abruption10.0AFP
42melanotic neuroectodermal tumor10.0SYP
43hemangiopericytoma10.0MUC1
44hypertension10.0CYP17A1
45hepatitis c10.0AFP
46leukemia10.0WT1
47testicular disease10.0SRY
48bladder carcinoma10.0NR5A1
49von hippel-lindau disease10.0INHA
50insulin resistance10.0CYP17A1

Graphical network of the top 20 diseases related to Sertoli-Leydig Cell Tumor:



Diseases related to sertoli-leydig cell tumor

Clinical Features for Sertoli-Leydig Cell Tumor

About this section

Drugs & Therapeutics for Sertoli-Leydig Cell Tumor

About this section
Sources:
5CenterWatch, 41NIH Clinical Center, 6ClinicalTrials, 60UMLS, 40NDF-RT
See all sources

Approved drugs:

Search CenterWatch for Sertoli-Leydig Cell Tumor

Drug clinical trials:

Search ClinicalTrials for Sertoli-Leydig Cell Tumor

Search NIH Clinical Center for Sertoli-Leydig Cell Tumor

Search CenterWatch for Sertoli-Leydig Cell Tumor

Genetic Tests for Sertoli-Leydig Cell Tumor

About this section

Anatomical Context for Sertoli-Leydig Cell Tumor

About this section
Sources:
32MalaCards
See all sources

MalaCards organs/tissues related to Sertoli-Leydig Cell Tumor:

32
Ovary, Testis, Skeletal muscle, Breast

Animal Models for Sertoli-Leydig Cell Tumor or affiliated genes

About this section
Sources:
36MGI
See all sources

MGI Mouse Phenotypes related to Sertoli-Leydig Cell Tumor:

36
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053799.7WT1, AFP, INHA, SRY
2MP:00053899.4WT1, AFP, NR5A1, INHA, INSL3, SRY
3MP:00053769.1AFP, NR5A1, MYOG, CYP17A1, PGR, THBD
4MP:00028738.6THBD, CALB2, WT1, DICER1, SYP, NR5A1
5MP:00053868.2CALB2, DICER1, AFP, NR5A1, MYOG, CYP17A1

Publications for Sertoli-Leydig Cell Tumor

About this section
Sources:
50PubMed
See all sources

Articles related to Sertoli-Leydig Cell Tumor:

(show top 50)    (show all 113)
idTitleAuthorsYear
1
A case of successful salvage chemotherapy of recurrent ovarian sertoli-leydig cell tumor. (24328002)
2013
2
Sertoli-Leydig cell tumor of the ovary: analysis of a single institution database. (22691037)
2013
3
Complete Androgen Insensitivity Syndrome with a Sertoli-Leydig Cell Tumor. (24333107)
2013
4
Fine needle aspiration cytology of Sertoli-Leydig cell tumors of ovary masquerading as dysgerminoma. (22102529)
2013
5
Sertoli-Leydig cell tumor of the ovary--morphological and immunohistochemical analysis. (22635079)
2012
6
Ovarian Sertoli-Leydig cell tumor in a 9-month-old infant with special histologic pattern. (22443217)
2012
7
The case reported as bilateral Sertoli-Leydig cell tumors in a 61-year-old woman with uterine aplasia may instead represent complete androgen insensitivity syndrome. (21623193)
2011
8
DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors. (21205968)
2011
9
Management of metastatic ovarian Sertoli-Leydig cell tumor with sporadic multinodular goiter: a case report and literature review. (21919698)
2011
10
Incidental detection of Sertoli-Leydig cell tumor by FDG PET/CT imaging in a patient with androgen insensitivity syndrome. (19957213)
2010
11
Postpartum hemorrhage from ruptured Sertoli-Leydig cell tumor: a case report. (21043371)
2010
12
Hyperandrogenism due to a testosterone-secreting Sertoli-Leydig cell tumor associated with a dehydroepiandrosterone sulfate-secreting adrenal adenoma in a postmenopausal woman: case presentation and review of literature. (19289327)
2009
13
Recurrent alpha-fetoprotein secreting Sertoli-Leydig cell tumor of ovary with an unusual presentation. (19282570)
2009
14
Bilateral Sertoli-Leydig cell tumor of the ovary: a rare case report. (19136796)
2009
15
Ovarian involvement by desmoplastic small round cell tumor with leydig cell hyperplasia showing an unusual immunophenotype (cytokeratin negative, calretinin and inhibin positive) mimicking poorly differentiated sertoli leydig cell tumor. (19851210)
2009
16
Sertoli-Leydig cell tumor: a rare ovarian neoplasm. Case report and review of literature. (18382911)
2008
17
Ovarian Sertoli-Leydig cell tumor with heterologous gastrointestinal epithelium as a source of alpha-fetoprotein: a case report. (18588618)
2008
18
Estrogen receptor alpha and progesterone receptor expression in ovarian adult granulosa cell tumors and Sertoli-Leydig cell tumors. (17885486)
2007
19
Immunohistochemical and ultrastructural analysis of a poorly differentiated pediatric age Sertoli-Leydig cell tumor. (17022971)
2007
20
Primary amenorrhea in a young Polish woman with complete androgen insensitivity syndrome and Sertoli-Leydig cell tumor: identification of a new androgen receptor gene mutation and evidence of aromatase hyperactivity and apoptosis dysregulation within the tumor. (17852420)
2007
21
Expression profile of ovarian tumors: distinct signature of Sertoli-Leydig cell tumor. (17177833)
2006
22
Ovarian Sertoli-Leydig cell tumor of intermediate grade with heterologous elements of rhabdomyosarcoma. A case report and a review of the literature. (16979522)
2006
23
Sertoli-Leydig cell tumor of ovary with heterologous element: a case report. (16366107)
2005
24
Sertoli-Leydig cell tumor of the ovary. (15216408)
2004
25
Overexpression of the BCL2 gene in a Sertoli-Leydig cell tumor of the ovary: a pathologic and cytogenetic study. (14734221)
2004
26
Sertoli-Leydig cell tumor of the ovary, a rare cause of precocious puberty in a 12-month-old infant. (11788622)
2002
27
Sertoli-Leydig cell tumor. (11205710)
2001
28
Trisomy 8 as sole karyotypic aberration in an ovarian metastasizing Sertoli-Leydig cell tumor. (11381376)
2001
29
Presence of 17 beta-hydroxysteroid dehydrogenase type 3 messenger ribonucleic acid transcript in an ovarian Sertoli-Leydig cell tumor. (9314929)
1997
30
Conservative management of Sertoli-Leydig cell tumor of the ovary. (9246972)
1997
31
Cervical sarcoma botryoides and ovarian Sertoli-Leydig cell tumor. (9345364)
1997
32
Sertoli-Leydig cell tumor of the ovary: a case report with endocrinologic observations. (15251509)
1996
33
Late presentation of an alpha-fetoprotein secreting isolated large upper abdominal retroperitoneal Sertoli-Leydig cell tumor recurrence. (7534742)
1995
34
In vitro production of cyclic AMP and steroids from an ovarian Sertoli-Leydig cell tumor. Notes on clinical management. (7732806)
1995
35
Sertoli-Leydig cell testicular tumor: case report and review of sex cord/gonadal stromal tumor histogenesis. (1512847)
1992
36
A case of ovarian Sertoli-Leydig cell tumor associated with high serum alpha-fetoprotein (AFP) concentration]. (1698212)
1990
37
Diagnosis and resection of an oral contraceptive-suppressible Sertoli-Leydig cell tumor with preservation of fertility and a 7-year follow-up. (2523030)
1989
38
Steroid biosynthesis in the Sertoli-Leydig cell tumor: effects of insulin and luteinizing hormone. (2532472)
1989
39
An unusual hormone pattern in a virilized woman affected by Sertoli-Leydig cell tumor. Report of a case. (2694756)
1989
40
Mixed Sertoli-Leydig cell tumor and rete testis adenocarcinoma in rats treated with CdCl2. (2834860)
1988
41
Demonstration of hydroxysteroid dehydrogenases and testosterone in the Sertoli-Leydig cell tumor (androblastoma) tissue of the human ovary: an enzyme histochemical and immunohistochemical study. (2984872)
1985
42
AFP-producing Sertoli-Leydig cell tumor of the ovary. (2409934)
1985
43
Arrested puberty associated with a Sertoli-Leydig cell tumor. (4003476)
1985
44
Sertoli-Leydig cell tumor of the ovary. (4019011)
1985
45
Steroid biosynthesis in the Sertoli-Leydig cell tumor tissue of the human ovary; enzymhistochemical and immunohistochemical studies. (6425925)
1984
46
Steroid metabolism in an androblastoma (Sertoli-Leydig cell tumor): a histopathological and biochemical study. (6327547)
1984
47
Sertoli-Leydig cell tumor of the ovary with heterologous elements and carcinoid: an immunohistochemical and ultrastructural study. (6367176)
1983
48
Sertoli-Leydig cell tumor of the ovary with teratomatous differentiation: clinicopathologic considerations. (7104958)
1982
49
Sertoli--Leydig cell tumor with endometroid differentiation. Case report and discussion of histogenesis. (7117116)
1982
50
Light and electron microscopic study of an intermediate sertoli-leydig cell tumor with a review of literatures in Japan. (1026031)
1976

Genetic Variations for Sertoli-Leydig Cell Tumor

About this section

Expression for genes affiliated with Sertoli-Leydig Cell Tumor

About this section
Sources:
1BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Sertoli-Leydig Cell Tumor

Search GEO for disease gene expression data for Sertoli-Leydig Cell Tumor.

Pathways for genes affiliated with Sertoli-Leydig Cell Tumor

About this section
Sources:
53Reactome, 37NCBI BioSystems Database
See all sources

Pathways related to Sertoli-Leydig Cell Tumor according to GeneCards/GeneDecks:

idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Hide members
10.0CYP17A1, HSD3B1
2
Hide members
10.0CYP17A1, HSD3B1
310.0PGR, INHA, NR5A1

Compounds for genes affiliated with Sertoli-Leydig Cell Tumor

About this section
Sources:
44Novoseek, 11DrugBank, 49PharmGKB, 59Tocris Bioscience, 28IUPHAR, 24HMDB, 2BitterDB
See all sources

Compounds related to Sertoli-Leydig Cell Tumor according to GeneCards/GeneDecks:

(show top 50)    (show all 100)
idCompoundScoreTop Affiliating Genes
1dmrt4410.3WT1, NR5A1, SRY
2estrogen4410.2MYOG, NR5A1, CALB2
3trilostane44 1111.1HSD3B1, HSD3BP4, PGR
4reticulin4410.1MUC1, SYP, KRT7
5s 1004410.1ENO2, MUC1, SYP
617beta-hydroxysteroid449.9NR5A1, HSD3BP4, PGR, CYP17A1
7forskolin44 49 1111.9ENO2, CYP17A1, MYOG, WT1
8letrozole44 49 59 1112.9SYP, PGR, CYP17A1
9dexamethasone44 49 28 1112.9ENO2, HSD3BP4, AFP, CYP17A1
10estrone44 28 11 2412.8NR5A1, CYP17A1, HSD3BP4, PGR, AFP
11androstenedione44 2410.8CYP17A1, INHA, HSD3BP4, HSD3B1
12progestin449.8HSD3BP4, PGR, MUC1, CYP17A1
13chloramphenicol44 2 1111.7CYP17A1, AFP, WT1, THBD, MUC1
14silver449.7SYP, ENO2, SRY, CALB2, AFP
15mucicarmine449.7CEACAM3, CALB2, SYP, MUC1, KRT7
16mifepristone44 59 28 1112.7PGR, MUC1, AFP, HSD3BP4
17dbc-amp449.7THBD, ENO2, SYP, CYP17A1
18dmso449.7PGR, AFP, MUC1, ENO2, THBD
19butyrate449.7MYOG, CALB2
20hyaluronic acid44 2410.6WT1, CALB2, MUC1, THBD, ENO2
21diethylstilbestrol44 28 1111.6CYP17A1, AFP, PGR, NR5A1, INSL3, ENO2
22sialic acid449.6CEACAM3, AFP, MUC1, KRT7, ENO2
23cysteine449.5MYOG, THBD, SYP, SRY, MUC1, PGR
243beta-hydroxysteroid449.5HSD3BP4, PGR, HSD3B1, INHA, CYP17A1, NR5A1
25methotrexate44 49 1111.5CEACAM3, ENO2, AFP, PGR, KRT7, MUC1
26hydrogen44 2410.5THBD, CEACAM3, INHA, CYP17A1, SYP, AFP
27cyclic amp44 2410.4MUC1, SYP, HSD3BP4, NR5A1, INHA, INSL3
28glycogen44 2410.4ENO2, MUC1, THBD, SYP, KRT7, AFP
29oligonucleotide449.3THBD, SRY, NR5A1, INHA, CYP17A1, MYOG
30b 723449.2KRT7, MUC1, THBD, CALB2, WT1, AFP
31estradiol44 11 2411.2HSD3BP4, AFP, CYP17A1, MUC1, INHA, PGR
32leucine449.2SYP, SRY, ENO2, NR5A1, CYP17A1, THBD
33alanine449.1AFP, CEACAM3, SRY, INHA, INSL3, PGR
34thymidine44 2410.1CEACAM3, AFP, WT1, ENO2, CYP17A1, MUC1
35acth449.0INHA, NR5A1, SYP, HSD3BP4, CYP17A1, ENO2
36creatinine449.0AFP, MYOG, SYP, MUC1, WT1, THBD
37ribonucleic acid448.9HSD3BP4, ENO2, PGR, INHA, MUC1, WT1
38hematoxylin448.9CALB2, SYP, CEACAM3, ENO2, KRT7, MLANA
39nitric oxide44 11 2410.9CEACAM3, ENO2, MUC1, MYOG, SYP, WT1
40serine448.8NR5A1, MUC1, THBD, CYP17A1, MYOG, SRY
41lipid448.8THBD, KRT7, AFP, MUC1, MYOG, SYP
42vegf448.6PGR, MYOG, AFP, ENO2, THBD, KRT7
43cholesterol44 28 11 2411.6HSD3BP4, HSD3B1, SYP, NR5A1, ENO2, CEACAM3
44retinoic acid44 249.5CYP17A1, ENO2, KRT7, THBD, PGR, MUC1
45tyrosine448.0ENO2, CALB2, WT1, AFP, SYP, MYOG
46calcium44 49 11 2411.0HSD3BP4, MYOG, SYP, CALB2, AFP, CYP17A1
47paraffin448.0AFP, CALB2, WT1, MLANA, CEACAM3, SYP
48testosterone44 59 11 2410.7MYOG, ENO2, HSD3B1, HSD3BP4, CALB2, WT1
49progesterone44 59 28 11 2411.6ENO2, KRT7, THBD, PGR, INHA, CYP17A1
50steroid447.6NR5A1, SYP, AFP, WT1, CALB2, HSD3BP4

GO Terms for genes affiliated with Sertoli-Leydig Cell Tumor

About this section
Sources:
16Gene Ontology
See all sources

Biological processes related to Sertoli-Leydig Cell Tumor according to GeneCards/GeneDecks:

(show all 10)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of female gonad developmentGO:200019510.3NR5A1, WT1
2ovulation from ovarian follicleGO:00154210.2PGR, AFP
3progesterone metabolic processGO:04244810.2AFP, CYP17A1
4positive regulation of male gonad developmentGO:200002010.1WT1, NR5A1, SRY
5cellular response to gonadotropin stimulusGO:07137110.1CYP17A1, WT1
6adrenal gland developmentGO:03032510.1CYP17A1, NR5A1, WT1
7glucocorticoid biosynthetic processGO:00670410.0CYP17A1, HSD3B1
8male gonad developmentGO:0085849.8SRY, INSL3, INHA, NR5A1, WT1
9androgen biosynthetic processGO:0067029.7CYP17A1, HSD3B1
10cell-cell signalingGO:0072679.7NR5A1, INHA, INSL3, PGR

Products for genes affiliated with Sertoli-Leydig Cell Tumor

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Sertoli-Leydig Cell Tumor

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
34MeSH
35MESH via Orphanet
36MGI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
50PubMed
51QIAGEN
57SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet